#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA663593	B	Effect of 0 nM compound on [3H]-DADL (4.2 nM) binding to higher affinity binding site of Opioid receptor delta 1 using LY-164929 (100 nM); expressed as % of control		1		single protein format	Scientific Literature
2.	ALA663594	B	Effect of 0 nM compound on [3H]DADL (4.2 nM) binding to lower affinity binding site of Opioid receptor delta 1 using DpLp (50 nM); expressed as % of control		1		single protein format	Scientific Literature
3.	ALA664673	B	Effect of 0 nM compound on [3H]DADL (4.2 nM) binding to lower affinity binding site of opioid receptor using DpLp (50 nM); expressed as % of control		2		single protein format	Scientific Literature
4.	ALA664674	B	Effect of 10 nM compound on [3H]FOXY (2.8 nM) binding to opioid receptor binding site using [3H]-DADL (4.2 nM); expressed as % of control		2		single protein format	Scientific Literature
5.	ALA664675	B	Effect of 1000 nM compound on [3H]FOXY (2.8 nM) binding to Opioid receptor delta 1 binding site using [3H]-DADL (4.2 nM); expressed as % of control		1		single protein format	Scientific Literature
6.	ALA664676	B	Effect of 1000 nM compound on [3H]FOXY (2.8 nM) binding to opioid receptor binding site using [3H]-DADL (4.2 nM); expressed as % of control		2		single protein format	Scientific Literature
7.	ALA664677	B	Effect of 10000 nM compound on [3H]DADL (4.2 nM) binding to lower affinity binding site of Opioid receptor delta 1 using DpLp (50 nM); expressed as % of control		1		single protein format	Scientific Literature
8.	ALA664678	B	Effect of 10000 nM compound on [3H]DADL (4.2 nM) binding to lower affinity binding site of opioid receptor using DpLp (50 nM); expressed as % of control		2		single protein format	Scientific Literature
9.	ALA665330	B	Effect of 1000 nM compound on [3H]DADL (4.2 nM) binding to higher affinity binding site of opioid receptor using LY-164929 (100 nM); expressed as % of control		2		single protein format	Scientific Literature
10.	ALA665331	B	Effect of 100 nM compound on [3H]DADL (4.2 nM) binding to lower affinity binding site of Opioid receptor delta 1 using DpLp (50 nM); expressed as % of control		1		single protein format	Scientific Literature
11.	ALA665471	B	Effect of 100 nM compound on [3H]DADL (4.2 nM) binding to lower affinity binding site of opioid receptor using DpLp (50 nM); expressed as % of control		3		single protein format	Scientific Literature
12.	ALA665472	B	Effect of 10 nM compound on [3H]DADL (4.2 nM) binding to higher affinity binding site of opioid receptor using LY-164929 (100 nM); expressed as % of control		2		single protein format	Scientific Literature
13.	ALA665473	B	The ability of compound to inhibit [3H]DADL binding to the Opioid receptor delta 1 of the NG108-15 cells at 10 min and 37 degree C		1		cell-based format	Scientific Literature
14.	ALA665474	B	Ability to displace [3H]DADL from delta opioid receptor		5		single protein format	Scientific Literature
15.	ALA665475	B	Ability to inhibit binding of SNC80 to delta opioid receptor		2		single protein format	Scientific Literature
16.	ALA665476	B	Binding affinity evaluated by inhibition of binding of [3H]DADLE to delta opioid receptor of rat brain	Rattus norvegicus	10		assay format	Scientific Literature
17.	ALA665477	B	Binding affinity against delta-opioid receptor by using [3H]DADLE as radioligand in rat brain		8		tissue-based format	Scientific Literature
18.	ALA665478	B	Affinity to delta opioid receptor determined in the presence of [3H]- [D-Pen2,5]enkephalin using membranes prepared from rat cerebrum		13		assay format	Scientific Literature
19.	ALA665479	B	Compound was tested for its ability to displace [3H]DADLE from delta receptor in rat brain.		8		tissue-based format	Scientific Literature
20.	ALA753987	B	Binding affinity towards Opioid receptor delta 1 using [3H]- [p-CIPhe4] DPDPE as radioligand at a concentration of 10 uM		1		single protein format	Scientific Literature